Showing results (91-100 of 753) with videos related to
Sort By:
Pageof 76
Current Cardiology Reports|September 20, 2012
Targeting high density lipoproteins in the prevention of cardiovascular disease?Daniel B Larach, Emil M deGoma, Daniel J RaderTrends in Molecular Medicine|September 6, 2015
Mining the social mediomeDavid A Asch, Daniel J Rader, Raina M MerchantCurrent Opinion in Lipidology|February 19, 2015
HDL re-examinedG Kees Hovingh, Daniel J Rader, Robert A HegeleThe Journal of Clinical Investigation|September 17, 2003
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgammaL Chastine Bell-Parikh, Tomomi Ide, John A Lawson, et al.Annals of Internal Medicine|February 3, 2005
Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarctionStephen E Kimmel, Jesse A Berlin, Muredach Reilly, et al.Cardiovascular Diabetology|May 4, 2007
Gene transfer of wild-type apoA-I and apoA-I Milano reduce atherosclerosis to a similar extentCorinna Lebherz, Julio Sanmiguel, James M Wilson, et al.Prostaglandins & Other Lipid Mediators|November 24, 2005
12/15-Lipoxygenase gene disruption and vitamin E administration diminish atherosclerosis and oxidative stress in apolipoprotein E deficient mice through a final common pathwayLei Zhao, Domenico Praticò, Daniel J Rader, et al.Atherosclerosis|September 5, 2002
Combined effects of cholesterol reduction and apolipoprotein A-I expression on atherosclerosis in LDL receptor deficient miceMasa-aki Kawashiri, YuZhen Zhang, Ellen Puré, et al.Current Atherosclerosis Reports|December 10, 2003
Noninvasive atherosclerosis imaging for predicting cardiovascular events and assessing therapeutic interventionsDouglas S Jacoby, Emile R Mohler III, Daniel J RaderJournal of Clinical Apheresis|May 10, 2005
Long-term effects of LDL apheresis in patients with severe hypercholesterolemiaBruce S Sachais, Julie Katz, Joyce Ross, et al.Pageof 76